Log In
BCIQ
Print this Print this
 

GeneSight

  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
DescriptionTest that detects single nucleotide polymorphisms (SNPs) in the cytochrome P450 2D6 (CYP2D6), cytochrome P450 2C19 (CYP2C19), serotonin (5-HT2A) receptor, and serotonin (5-HT) transporter (SLC6A4; SERT) genes
Molecular Target Cytochrome P450 2D6 (CYP2D6) ; Cytochrome P450 2C19 (CYP2C19)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationNeurology, Diagnostic
Indication DetailsPredict response to psychiatric medications
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$410.0M

$225.0M

$185.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/01/2016

$410.0M

$225.0M

$185.0M

Get a free BioCentury trial today